NCT04776395 2026-04-17Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple MyelomaEmory UniversityPhase 2 Recruiting68 enrolled
NCT03937635 2026-04-03Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaEastern Cooperative Oncology GroupPhase 3 Recruiting288 enrolled